Table 4.
Outcome | Normal | After 3 months | After 6 months | P |
---|---|---|---|---|
All survivors (n=85), mean±SD | 486±72 | 526±82 | 0.001* | |
Age groups (years) | ||||
20-30 (n=25) | ||||
Men (n=12) | ||||
Mean±SD | 652±102 | 478±68 | 559±83 | 0.001* |
Mean difference (95% CI) | −174 (−198-−126) | −93 (−120-−55)** | ||
Women (n=13) | ||||
Mean±SD | 600±80 | 462±71 | 490±86 | 0.001* |
Mean difference (95% CI) | −138 (−170-−80) | −110 (−140-−60)** | ||
31-40 (n=35) | ||||
Men (n=20) | ||||
Mean±SD | 650±90 | 512±78 | 550±88 | 0.001* |
Mean difference (95% CI) | −138 (−188-−90) | −100 (−140-−60)** | ||
Women (n=15) | ||||
Mean±SD | 615±85 | 470±66 | 492±80 | 0.001* |
Mean difference (95% CI) | −145 (−195-−95) | −123 (−152-−80)** | ||
41-50 (n=16) | ||||
Men (n=10) | ||||
Mean±SD | 620±70 | 470±65 | 530±73 | 0.001* |
Mean difference (95% CI) | −150 (−192-−87) | −90 (−142-−43)** | ||
Women (n=6) | ||||
Mean (SD) | 520±60 | 402±72 | 462±78 | 0.001* |
Mean difference (95% CI) | −118 (−155-−64) | −58 (−112-−30)** | ||
>50 (n=9) | ||||
Men (n=6) | ||||
Mean±SD | 580±64 | 410±82 | 464±82 | 0.001* |
Mean difference (95% CI) | −170 (−210-−90) | −116 (− 165-−85) | ||
Women (n=3) | ||||
Mean±SD | 535±72 | 399±94 | 377±88 | 0.001* |
Mean difference (95% CI) | −136 (−180-−96) | −158 (−210-−90)** |
*= significance. SD=Standard deviation, CI=Confidence interval